EWASdb: epigenome-wide association study database

       EWASdb : epigenome-wide association study database


EWAS for single marker      EWAS for KEGG Pathway      EWAS for GO Category      Browers by class      Browers by alph      FAQ

The data is big,please wait a moment......

Search Result for GO Categories

Total 1094 records 15/110 page first << upPage 11121314 15 downPage >> last

EWAS ID GO ID Class Disease/Phenotype
[sample size n]
Sample groups
(case/control, trait, cell type etc.)
Categories GO Term Name GO Term Gene Number Gene Number Annotated In The GO Term Pvalue
Group1
[sample size n]
Group2
[sample size n]
EWAS1296 GO:0005085 disease multiple sclerosis
[n=96]
multiple sclerosis patients treated with fumaric acid esters(FAE)
[n=42]
untreated/treatment naive multiple sclerosis patients(Naive)
[n=54]
molecular_function guanyl-nucleotide exchange factor activity 151 131 0.000000
EWAS1296 GO:0005088 disease multiple sclerosis
[n=96]
multiple sclerosis patients treated with fumaric acid esters(FAE)
[n=42]
untreated/treatment naive multiple sclerosis patients(Naive)
[n=54]
molecular_function Ras guanyl-nucleotide exchange factor activity 83 73 0.000007
EWAS1296 GO:0005089 disease multiple sclerosis
[n=96]
multiple sclerosis patients treated with fumaric acid esters(FAE)
[n=42]
untreated/treatment naive multiple sclerosis patients(Naive)
[n=54]
molecular_function Rho guanyl-nucleotide exchange factor activity 68 59 0.000114
EWAS1296 GO:0005096 disease multiple sclerosis
[n=96]
multiple sclerosis patients treated with fumaric acid esters(FAE)
[n=42]
untreated/treatment naive multiple sclerosis patients(Naive)
[n=54]
molecular_function GTPase activator activity 245 197 0.000007
EWAS1296 GO:0005887 disease multiple sclerosis
[n=96]
multiple sclerosis patients treated with fumaric acid esters(FAE)
[n=42]
untreated/treatment naive multiple sclerosis patients(Naive)
[n=54]
cellular_component integral to plasma membrane 1113 907 0.000000
EWAS1296 GO:0005125 disease multiple sclerosis
[n=96]
multiple sclerosis patients treated with fumaric acid esters(FAE)
[n=42]
untreated/treatment naive multiple sclerosis patients(Naive)
[n=54]
molecular_function cytokine activity 176 142 0.000073
EWAS1296 GO:0005126 disease multiple sclerosis
[n=96]
multiple sclerosis patients treated with fumaric acid esters(FAE)
[n=42]
untreated/treatment naive multiple sclerosis patients(Naive)
[n=54]
molecular_function cytokine receptor binding 168 136 0.000073
EWAS1296 GO:0005158 disease multiple sclerosis
[n=96]
multiple sclerosis patients treated with fumaric acid esters(FAE)
[n=42]
untreated/treatment naive multiple sclerosis patients(Naive)
[n=54]
molecular_function insulin receptor binding 28 26 0.000315
EWAS1296 GO:0005160 disease multiple sclerosis
[n=96]
multiple sclerosis patients treated with fumaric acid esters(FAE)
[n=42]
untreated/treatment naive multiple sclerosis patients(Naive)
[n=54]
molecular_function transforming growth factor beta receptor binding 19 19 0.000000
EWAS1296 GO:0005178 disease multiple sclerosis
[n=96]
multiple sclerosis patients treated with fumaric acid esters(FAE)
[n=42]
untreated/treatment naive multiple sclerosis patients(Naive)
[n=54]
molecular_function integrin binding 62 55 0.000040

Total 1094 records 15/110 page first << upPage 11121314 15 downPage >> last